Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Eur Arch Otorhinolaryngol ; 273(9): 2613-20, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27156084

ABSTRACT

To study effectiveness of surgery and watchful waiting in localized laryngeal amyloidosis, retrospective case series. This retrospective study comprises all consecutive patients with localized laryngeal amyloidosis surgically treated in a tertiary hospital between 1994 and February 2016. Recurrence rate, revision surgery, progression to systemic amyloidosis, and changes in voice were monitored yearly. Eighteen patients were included. Seven women and eleven men had a median age 50 years (range 21-77 years) and median follow-up 6.4 years (2.4-17 years). Amyloid was located in subglottis (5), glottis (8), false vocal folds (8) and other supraglottic areas (5), in more than one laryngeal region (13) and bilaterally (12). Cold steel excision was used at the glottis; CO2 laser excision, sometimes assisted by microdebrider, at other laryngeal areas. Eleven patients needed revision surgery, ten within the first 4 years after surgical treatment. One patient needed his first revision surgery after 11 years. Five patients needed a second revision within 6 years after initial diagnosis. Two patients needed a third revision. Indications for first revision surgery were progression (8) with dysphonia (7), dyspnea (2), dysphagia (1), exclusion of malignancy (1), and aphonia (1). No patient developed systemic amyloidosis during follow-up. Although local progression of amyloid necessitates revision surgery once or twice in the first 4-6 years, progression slows down thereafter. Late progression, however, remains possible.


Subject(s)
Amyloidosis/surgery , Laryngeal Diseases/surgery , Adult , Aged , Amyloidosis/complications , Amyloidosis/diagnosis , Female , Follow-Up Studies , Humans , Laryngeal Diseases/complications , Laryngeal Diseases/diagnosis , Male , Middle Aged , Recurrence , Retrospective Studies , Treatment Outcome , Young Adult
2.
Otol Neurotol ; 34(2): 220-6, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23295729

ABSTRACT

OBJECTIVE: To study objective or subjective preoperative factors predicting improvement in listening capabilities and patient satisfaction after stapes surgery in otosclerosis. STUDY DESIGN: Prospective, multicenter study. SETTING: Two tertiary referral centers. PATIENTS: Fifty-four consecutive adult patients with otosclerosis. INTERVENTIONS: Stapedotomy, stapedectomy. MAIN OUTCOME MEASURES: Pure tone and speech audiometry and questionnaires were assessed preoperatively and repeated 6 months postoperatively. The questionnaires consisted of a visual analogue scale (VAS, 0-10) to score the overall quality of life, and the Operation Benefit Profile to assess the listening capability in various circumstances. Stereophony, defined by the Belfast rule of thumb, was used to divide the patients in 3 categories having unilateral, symmetric bilateral, or asymmetric bilateral hearing loss. RESULTS: Six patients were considered early failures of surgery, and 8 patients were lost to follow-up. In the remaining 40 patients (43 ears), all audiometric parameters improved significantly. The postoperative air-bone gap was less than 10 dB in 70%. The postoperative average air conduction threshold was less than 30 dB in 49%. The postoperative quality of life was excellent (VAS, ≥9) in 45% and did not correlate with any preoperative parameter. Preoperative and postoperative overall listening capabilities correlated slightly (Spearman r, 0.47). The postoperative VAS correlated with all postoperative audiometric parameters and the Operation Benefit Profile. CONCLUSION: Uncomplicated stapes surgery itself is the only predictor of improvement in listening capabilities and patient satisfaction 6 months after stapes surgery in otosclerosis.


Subject(s)
Otosclerosis/physiopathology , Otosclerosis/surgery , Patient Satisfaction , Stapes Surgery , Activities of Daily Living , Adolescent , Adult , Aged , Aged, 80 and over , Audiometry , Bone Conduction , Disability Evaluation , Female , Functional Laterality/physiology , Humans , Male , Middle Aged , Prospective Studies , Quality of Life , Reoperation , Speech Perception/physiology , Surveys and Questionnaires , Treatment Outcome , Young Adult
3.
Laryngoscope ; 119(3): 608-15, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19235761

ABSTRACT

OBJECTIVE: To study the clinical and pathological characteristics of two patients with laryngeal apolipoprotein A-I (apoA-I)-derived (AApoAI) amyloidosis with the apolipoprotein A-I variants Leu174Ser and Leu178Pro, respectively. The latter variant has not been associated with amyloid before. STUDY DESIGN: Descriptive report of two patients who presented with laryngeal amyloid presumed to be of localized AL type, but in who further assessments demonstrated systemic amyloidosis. METHODS: The larynx was examined by videolaryngostroboscopy. The voice was analyzed with the GRBAS system, phonation times, and phonetography. Laryngeal biopsies were stained with Congo red and analyzed immunohistochemically. Organ function was assessed and tissue involvement by amyloid further determined by rectal biopsy, abdominal fat tissue aspirate, and serum amyloid P component scintigraphy. RESULTS: The appearance of the laryngeal amyloid was unusual in both patients, occurring as small, irregular floppy proliferations affecting the borders of both vocal folds. Amyloid was stained with antibodies to apoA-I and not with antibodies to immunoglobulin light chains. The 45-year-old woman with the previously described amyloidogenic apoA-I Leu174Ser variant had possible involvement by amyloid in joints, peripheral nerves, and heart. Whereas in the 67-year-old man with apoA-I Leu178Pro there was a clinical suggestion of autonomic and cardiac amyloid and histological corroboration of systemic amyloidosis in abdominal fat. CONCLUSIONS: Laryngeal symptoms may be the presenting feature of hereditary systemic AApoAI amyloidosis, and comprehensive investigations including apoA-I genotyping are warranted in patients who present with apparently localized laryngeal amyloidosis. The distinctive appearance of the amyloidotic vocal folds described here may further signal the possibility of hereditary AApoAI type.


Subject(s)
Amyloidosis/complications , Apolipoprotein A-I/metabolism , Laryngeal Diseases/etiology , Aged , Amyloidosis/genetics , Amyloidosis/metabolism , Biopsy , DNA/genetics , DNA Mutational Analysis , Diagnosis, Differential , Female , Humans , Laryngeal Diseases/genetics , Laryngeal Diseases/metabolism , Laryngoscopy , Larynx/diagnostic imaging , Larynx/pathology , Male , Middle Aged , Mutation , Radiography , Radionuclide Imaging , Video Recording
4.
J Mol Cell Cardiol ; 41(1): 86-96, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16780869

ABSTRACT

Within the phenotypically and functionally heterogeneous group of circulating progenitor cells (CPC), a subclass of cells with vascular repair potential have been identified. These CPC are detected and isolated based on single or combined expression of CD34, CD133 and VEGFR-2, and referred to as endothelial progenitor cells. Here we asked whether CPC subsets defined by single expression of these markers exhibit functional heterogeneity. As functional parameters, we chose the capacity of CPC to differentiate into endothelial cells. Moreover, we studied their role in remodeling by recruitment of inflammatory cells, an aspect that has been little explored. We established an in vivo model in which the intrinsic functional capacity of these human CPC subsets was studied. Human CD34+ CPC, but not CD133+ or VEGFR-2+ CPC, seeded in Matrigel pellets and transplanted subcutaneously in a nude mouse host, contributed little to donor-derived neovascularization. However, host angiogenesis in the Matrigel implant, as demonstrated by the presence of capillaries containing erythrocytes and expressing mouse CD31, was strong in response to implantation of human CD34+ CPC and significantly lower in response to the other two CPC subsets. Moreover, the CD34+ CPC subset was significantly superior to CD133+ CPC and VEGFR-2+ CPC in the recruitment of host monocytes/macrophages. These three CPC populations were further dissected into seven discrete subsets, based on three-parameter flow cytometry analysis of combined expression patterns of CD34, CD133 and VEGFR-2. In conclusion, in our system, CD34+ CPC contribute marginally to neovascularization by differentiation but are potent regulators of the host angiogenic and pro-inflammatory response, suggesting a possible role for these cells in the remodeling of vascular lesions.


Subject(s)
Antigens, CD34/metabolism , Hematopoietic Stem Cells/immunology , Inflammation/immunology , Neovascularization, Physiologic/immunology , AC133 Antigen , Animals , Antigens, CD/genetics , Antigens, CD/metabolism , Antigens, CD34/genetics , Cell Differentiation , Collagen , Drug Combinations , Endothelium, Vascular/cytology , Endothelium, Vascular/immunology , Flow Cytometry/methods , Glycoproteins/genetics , Glycoproteins/metabolism , Hematopoietic Stem Cell Transplantation/methods , Humans , Laminin , Male , Mice , Mice, Nude , Peptides/genetics , Peptides/metabolism , Proteoglycans , Transcription, Genetic , Vascular Endothelial Growth Factor Receptor-2/genetics , Vascular Endothelial Growth Factor Receptor-2/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL